Q9V2J8 (Q9V2J8_PYRAB) Pyrococcus abyssi (strain GE5 / Orsay)
Glycogen synthase UniProtKBAFDB90v4InterProSTRINGInteractive Modelling
437 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
34 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of inactive 5-HT5AR in complex with AS2674723 |
Heteromer P47898; | 1×PGE; 3×PEG; 1×PG4; 1×1PE; 1×NN6; | ||||
| Assess | ||||||
| High resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agoni… |
Heteromer Q03431; Q27IM2; | 1×NAG; 1×NAG; 1×NAG; 3×MAN; 9×OLA; 1×ACY; 1×PG4; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of Pyrococcus abyssi glycogen synthase with open and closed conformations | homo-3-mer | 3×TRS; 3×PO4; 1×NHF; | ||||
| Assess | ||||||
| Crystal structure of human alpha2C adrenergic G protein-coupled receptor. | homo-2-mer | 2×E33; 2×CLR; 7×OLC; 2×OLA; | ||||
| Assess | ||||||
| Structure of glycogen synthase from Pyrococcus abyssi | monomer | 1×GLC; 4×DIO; 3×GOL; | ||||
| Assess | ||||||
| Crystal structure of monomeric glycogen synthase from Pyrococcus abyssi | monomer | 1×GLC; 3×K; 3×CL; 2×GOL; | ||||
| Assess | ||||||
| Structure of the C domain of glycogen synthase from Pyrococcus abyssi | monomer | 4×SO4; 2×ACT; | ||||
| Assess | ||||||
| Crystal structure of human orexin 2 receptor bound to the selective antagonist EMPA determined by t… | monomer | 1×7MA; 5×OLA; 1×1PE; | ||||
| Assess | ||||||
| Crystal structure of the Neurokinin 1 receptor in complex with the small molecule antagonist Netupi… | monomer | 1×GAW; 1×CIT; 9×OLA; 7×OLC; 24×PEG; | ||||
| Assess | ||||||
| Crystal structures of human orexin 2 receptor bound to the selective antagonist EMPA determined by … | monomer | 1×7MA; 4×OLA; 2×1PE; | ||||
| Assess | ||||||
| Crystal structure of the Neurokinin 1 receptor in complex with the small molecule antagonist Aprepi… | monomer | 1×GBQ; 1×CIT; 17×OLA; 3×OLC; | ||||
| Assess | ||||||
| Crystal structure of the human OX2 orexin receptor bound to the insomnia drug Suvorexant | monomer | 1×SUV; 1×OLA; | ||||
| Assess | ||||||
| High-resolution crystal structure of the human CB1 cannabinoid receptor | monomer | 9×PEG; 4×SO4; 1×7DY; | ||||
| Assess | ||||||
| Crystal structure of the Orexin-2 receptor in complex with HTL6641 at 2.61 A resolution | monomer | 1×NU8; 2×NO3; 2×PG4; 4×OLA; | ||||
| Assess | ||||||
| Crystal structure of the allosteric modulator ZCZ011 binding to CP55940-bound cannabinoid receptor 1 | monomer | 2×CLR; 1×9GF; 1×7IC; 2×PEG; 4×GOL; 2×OLC; 4×OLA; | ||||
| Assess | ||||||
| Crystal structure of the Orexin-2 receptor in complex with suvorexant at 2.76 A resolution | monomer | 13×OLA; 1×SUV; 2×NH4; 1×PG4; | ||||
| Assess | ||||||
| Crystal structure of the Orexin-2 receptor in complex with EMPA at 2.74 A resolution | monomer | 1×7MA; 1×PG4; 1×OLA; | ||||
| Assess | ||||||
| Crystal structure of the Melanocortin-4 Receptor (MC4R) in complex with SHU9119 | monomer | 1×CA; 8×OLA; | ||||
| Assess | ||||||
| Structures of the human OX1 orexin receptor bound to selective and dual antagonists | monomer | 1×SUV; 6×OLA; | ||||
| Assess | ||||||
| Crystal structure of the protein 1 | monomer | 1×1QW; 2×OLC; 6×PEG; 1×FMT; 1×F5O; | ||||
| Assess | ||||||
| XFEL crystal structure of human melatonin receptor MT1 in complex with ramelteon | monomer | 1×JEV; 2×OLA; 1×PEG; | ||||
| Assess | ||||||
| Structures of the human OX1 orexin receptor bound to selective and dual antagonists | monomer | 1×4OT; 2×OLA; | ||||
| Assess | ||||||
| XFEL crystal structure of human melatonin receptor MT1 in complex with 2-phenylmelatonin | monomer | 1×JEY; 1×OLA; 1×PEG; | ||||
| Assess | ||||||
| Crystal Structure of Human Gastrin Releasing Peptide Receptor in complex with the antagonist PD1762… | monomer | 1×8B8; | ||||
| Assess | ||||||
| The structural study of mutation induced inactivation of Human muscarinic receptor M4 | monomer | |||||
| Assess | ||||||
| Crystal structure of a class A GPCR | monomer | 1×EBX; | ||||
| Assess | ||||||
| XFEL crystal structure of human melatonin receptor MT1 in complex with 2-iodomelatonin | monomer | 1×ML2; 1×PEG; 1×GOL; | ||||
| Assess | ||||||
| XFEL crystal structure of human melatonin receptor MT1 in complex with agomelatine | monomer | 1×AWY; 1×OLA; | ||||
| Assess | ||||||
| Structure of an allosteric modulator bound to the CB1 cannabinoid receptor | monomer | 1×9GF; 1×9GL; 4×OLA; 2×OLC; 2×PEG; | ||||
| Assess | ||||||
| Crystal structure of the Neurokinin 1 receptor in complex with the small molecule antagonist CP-99,… | monomer | 1×GBK; | ||||
| Assess | ||||||
| XFEL MT1R structure by ligand exchange from agomelatine to 2-phenylmelatonin. | monomer | 1×JEY; | ||||
| Assess | ||||||
| Crystal structure of the human NK1 tachykinin receptor | monomer | 1×L76; | ||||
| Assess | ||||||
| Structure-based development of subtype-selective orexin 1 receptor antagonists | monomer | 1×JHC; 1×CLR; 1×OLA; | ||||
| Assess | ||||||
| Cryo-EM structure of the unliganded mSMO-PGS2 in a lipidic environment | monomer | 1×CLR; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3fro.1.A | homo-3-mer | 0.89 | 1×NHF; | 100.00 | ||
| Assess | ||||||
| 7w41.1.A | monomer | 0.74 | 83.33 | |||
| Assess | ||||||